Posttransplantation lymphoproliferative disorder: Endoscopic findings

Journal of Pediatric Gastroenterology and Nutrition

Volumn 31, Issue 4, 2000, Pages 458-461

  O'Connor, J A ^a   Cogley, C ^a   Burton, M ^a   Lancaster Weiss, K ^a   Cordle, R A ^a  

^a WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

Endoscopy; Epstein Barr virus; Pediatric; Posttransplantation lymphoproliferative disorder

Indexed keywords

MERCAPTOPURINE; PREDNISONE; TSUKUBAENOLIDE;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE CLASSIFICATION; ENDOSCOPIC SURGERY; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; INFANT; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; ENDOSCOPY, GASTROINTESTINAL; EPSTEIN-BARR VIRUS INFECTIONS; ESOPHAGOSCOPY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISORDERS; MALE;

EID: 0033818996     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200010000-00026     Document Type: Article

References (11)

1. Epstein-Barr virus lymphoproliferative disorders after liver transplantation
2. Post-transplant lymphoproliferative disorder
3. Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: Implications for understanding their pathogenesis and developing rational treatment strategies
4. The involvement of the gastrointestinal tract in posttransplant lymphoproliferative disease in pediatric liver transplantation
5. Posttransplant lymphoproliferative disease in pediatric liver transplantation: Interplay between primary Epstein-Barr virus infection and immunosuppression
6. An increased incidence of Epstein-Barr virus infection and lymphoproliferative in young children on FK506 after liver transplantation
7. Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus
8. Remission of posttransplant lymphoproliferative disease after interferon-alfa therapy
9. Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy
10. Treatment of posttransplant lymphoproliferative disease in the central nervous system of a lung transplant using allogeneic lymphocytes
11. The role of endoscopy in diagnosis of lymphoproliferative disorder in the gastrointestinal tract of children after liver transplantation